The recommendation was given after reviewing very rare cases of unusual blood clots occurring in the United States after the vaccine.
Six cases of cerebral venous sinus thrombosis (CVST) have occurred in the United States, most of them in association with low levels of blood platelets.
Earlier, Johnson and Johnson had started shipping vaccines to countries in the European Union.
The company then requested that the deployment be delayed to give time to clarify.
However, the EMA said the vaccine could be used without restriction and that the vaccine’s benefits in preventing COVID-19 outweighed the risks of side effects.
U.S. regulatory authorities suspended use of the vaccine earlier, after some 6.8 million people received the vaccine there.
Short Link: https://wp.me/pcj2iU-3yZ2
- Eid -el-Fitr: Gov. Ganduje frees 123 prison inmates
- Coronavirus – Malawi: Daily update of information on COVID-19 (May 13, 2021)
- World Bank to construct 13.16km Lagos farm roads
- Coronavirus – Ethiopia: COVID-19 cases reported in Ethiopia (May 13, 2021)
- Eid el-fitri: Cleric preaches unity, tolerance to check ethnicity
- Cargo Airport project ‘ll increase economic fortunes of Anambra- ONICCIMA
- FIFA World Report: Give Every Talent a Chance
- Diaspora voting critical to effective participation in governance – council
- Visit Rwanda and RwandAir join the Basketball Africa League as official partners